Merck IIT: RRP Pembro and Lenvatinib

Clinical trial NCT04645602 · RECRUITING

Trial details

NCT number: NCT04645602
Sponsor: Yale University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus Recurrent Respiratory Papillomatosis Pulmonary Disease

Start date: 2025-07-18
Primary completion: 2027-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.